PTI-428
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
Proteostasis Therapeutics, Inc.
Overview
PTI-428 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
PTI-428 clinical trials
Explore related
Medical disclaimer. This page summarizes research about PTI-428 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.